SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013308
Filing Date
2022-08-11
Accepted
2022-08-11 16:25:27
Documents
86
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20220630x10q.htm   iXBRL 10-Q 2499719
2 EX-10.1 kala-20220630xex10d1.htm EX-10.1 69809
3 EX-10.2 kala-20220630xex10d2.htm EX-10.2 65338
4 EX-31.1 kala-20220630xex31d1.htm EX-31.1 15205
5 EX-31.2 kala-20220630xex31d2.htm EX-31.2 15179
6 EX-32.1 kala-20220630xex32d1.htm EX-32.1 6729
7 EX-32.2 kala-20220630xex32d2.htm EX-32.2 6841
  Complete submission text file 0001558370-22-013308.txt   9307896

Data Files

Seq Description Document Type Size
8 EX-101.SCH kala-20220630.xsd EX-101.SCH 61580
9 EX-101.CAL kala-20220630_cal.xml EX-101.CAL 60501
10 EX-101.DEF kala-20220630_def.xml EX-101.DEF 280678
11 EX-101.LAB kala-20220630_lab.xml EX-101.LAB 518696
12 EX-101.PRE kala-20220630_pre.xml EX-101.PRE 409979
80 EXTRACTED XBRL INSTANCE DOCUMENT kala-20220630x10q_htm.xml XML 1607583
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 221156256
SIC: 2834 Pharmaceutical Preparations